ARTICLE | Clinical News
Therakos Cellex photopheresis system regulatory update
March 30, 2009 7:00 AM UTC
FDA approved a PMA from Johnson & Johnson's Therakos Inc. subsidiary for its Therakos Cellex Photopheresis System for the palliative treatment of skin manifestations of cutaneous T cell lymphoma (CTC...